Trials / Completed
CompletedNCT02004119
Phase 2 Study of KHK4577
Randomized Double-blind Placebo-controlled Study of KHK4577 in Patients With Atopic Dermatitis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 93 (actual)
- Sponsor
- Kyowa Kirin Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
This study is an randomized double-blind placebo-controlled study to evaluate the efficacy and the safety of oral KHK4577 for 6 weeks in patients with atopic dermatitis. Pharmacokinetics of KHK4577 will also be assessed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KHK4577 | |
| DRUG | Placebo |
Timeline
- Start date
- 2013-11-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2013-12-06
- Last updated
- 2018-09-11
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02004119. Inclusion in this directory is not an endorsement.